RIIAD1
gene geneOn this page
Also known as FLJ36032
Summary
RIIAD1 (regulatory subunit of type II PKA R-subunit domain containing 1, HGNC:26686) is a protein-coding gene on chromosome 1q21.3, encoding RIIa domain-containing protein 1 (A6NNX1).
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 14 total
- MANE Select transcript:
NM_001144956
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26686 |
| Approved symbol | RIIAD1 |
| Name | regulatory subunit of type II PKA R-subunit domain containing 1 |
| Location | 1q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ36032 |
| Ensembl gene | ENSG00000178796 |
| Ensembl biotype | protein_coding |
| Entrez | 284485 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding_CDS_not_defined, 2 protein_coding
ENST00000326413, ENST00000426175, ENST00000427205, ENST00000451222, ENST00000451484, ENST00000479191
RefSeq mRNA: 1 — MANE Select: NM_001144956
NM_001144956
CCDS: CCDS53368
Canonical transcript exons
ENST00000479191 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001704762 | 151721522 | 151721620 |
| ENSE00001747416 | 151729488 | 151729805 |
| ENSE00003501869 | 151728766 | 151728893 |
| ENSE00003590061 | 151722086 | 151722162 |
| ENSE00003670168 | 151727575 | 151727621 |
Expression profiles
Bgee: expression breadth ubiquitous, 177 present calls, max score 98.94.
FANTOM5 (CAGE): breadth broad, TPM avg 0.8435 / max 95.3391, expressed in 212 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 5241 | 0.7312 | 193 |
| 5244 | 0.1123 | 54 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 98.94 | gold quality |
| secondary oocyte | CL:0000655 | 96.75 | gold quality |
| bronchial epithelial cell | CL:0002328 | 95.89 | gold quality |
| bronchus | UBERON:0002185 | 94.54 | gold quality |
| right uterine tube | UBERON:0001302 | 93.52 | gold quality |
| pituitary gland | UBERON:0000007 | 92.70 | gold quality |
| sperm | CL:0000019 | 91.45 | gold quality |
| adenohypophysis | UBERON:0002196 | 91.08 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.48 | gold quality |
| oviduct epithelium | UBERON:0004804 | 88.10 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 87.82 | gold quality |
| nucleus accumbens | UBERON:0001882 | 86.34 | gold quality |
| amygdala | UBERON:0001876 | 85.66 | gold quality |
| endothelial cell | CL:0000115 | 84.61 | silver quality |
| islet of Langerhans | UBERON:0000006 | 83.39 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 83.36 | gold quality |
| caudate nucleus | UBERON:0001873 | 83.35 | gold quality |
| putamen | UBERON:0001874 | 82.54 | gold quality |
| fallopian tube | UBERON:0003889 | 82.33 | gold quality |
| prefrontal cortex | UBERON:0000451 | 81.81 | gold quality |
| left testis | UBERON:0004533 | 81.17 | gold quality |
| right testis | UBERON:0004534 | 80.88 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 80.48 | gold quality |
| hypothalamus | UBERON:0001898 | 80.47 | gold quality |
| right atrium auricular region | UBERON:0006631 | 80.42 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 80.42 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 80.14 | gold quality |
| forebrain | UBERON:0001890 | 79.75 | gold quality |
| apex of heart | UBERON:0002098 | 79.63 | gold quality |
| testis | UBERON:0000473 | 79.56 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-10287 | yes | 25.67 |
| E-MTAB-7316 | yes | 22.75 |
| E-ANND-3 | yes | 9.54 |
| E-MTAB-9388 | yes | 7.11 |
| E-GEOD-125970 | no | 3.65 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
6 targeting RIIAD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
| HSA-MIR-4663 | 99.62 | 65.33 | 957 |
| HSA-MIR-6859-3P | 97.26 | 64.69 | 428 |
| HSA-MIR-6836-3P | 97.08 | 64.99 | 712 |
| HSA-MIR-6846-3P | 94.80 | 65.19 | 389 |
| HSA-MIR-450A-5P | 93.89 | 64.57 | 50 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| ENSDARG00000098861 | ||
| mus_musculus | Riiad1 | ENSMUSG00000028139 |
| rattus_norvegicus | Riiad1 | ENSRNOG00000037310 |
Paralogs (2): SPA17 (ENSG00000064199), GAP43 (ENSG00000172020)
Protein
Protein identifiers
RIIa domain-containing protein 1 — A6NNX1 (reviewed: A6NNX1)
All UniProt accessions (2): A6NNX1, C9JPK7
RefSeq proteins (1): NP_001138428* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003117 | cAMP_dep_PK_reg_su_I/II_a/b | Domain |
| IPR059162 | RIIAD1 | Domain |
Pfam: PF02197
UniProt features (2 total): chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NNX1-F1 | 90.99 | 0.81 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 25 (showing top):
chr1q21, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED, MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED, PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7, CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP, FOXN3_TARGET_GENES, HDAC4_TARGET_GENES, NCOA2_TARGET_GENES, SOX3_TARGET_GENES, MIR6859_3P, GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_UP, GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS, GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS, WP_ENDOTHELIN_PATHWAYS
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
226 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RIIAD1 | FAM89B | Q8N5H3 | 562 |
| RIIAD1 | TEX55 | Q96M34 | 529 |
| RIIAD1 | SLC66A2 | Q8N2U9 | 466 |
| RIIAD1 | EFCAB10 | A6NFE3 | 447 |
| RIIAD1 | TCTA | P57738 | 430 |
| RIIAD1 | SMIM5 | Q71RC9 | 422 |
| RIIAD1 | STMP1 | E0CX11 | 392 |
| RIIAD1 | CATIP | Q7Z7H3 | 373 |
| RIIAD1 | ROPN1B | Q9BZX4 | 370 |
| RIIAD1 | SCOC | Q9UIL1 | 348 |
| RIIAD1 | TPGS1 | Q6ZTW0 | 343 |
| RIIAD1 | PRPF38B | Q5VTL8 | 335 |
| RIIAD1 | TMEM212 | A6NML5 | 333 |
| RIIAD1 | KIAA1549L | Q6ZVL6 | 328 |
| RIIAD1 | CFAP126 | Q5VTH2 | 326 |
IntAct
0 interactions, top by confidence:
BioGRID (5): RIIAD1 (Two-hybrid), RIIAD1 (Two-hybrid), RIIAD1 (Two-hybrid), RIIAD1 (Two-hybrid), RIIAD1 (Affinity Capture-MS)
ESM2 similar proteins: A0JMA8, A1A5P5, A6NNX1, E7F187, O43150, O46470, O54829, O94376, P45966, P47822, P49758, P49802, P49803, Q0VIA1, Q23288, Q23679, Q2KI89, Q2NKU6, Q32PB2, Q3KNY5, Q3ZCF2, Q4R6I5, Q4R6W4, Q5M6W3, Q5R629, Q5R6P5, Q5U245, Q5XIR8, Q61Z20, Q626S1, Q6CT76, Q6CVN3, Q6DJ25, Q6IP67, Q6IQX0, Q6VBQ6, Q758M1, Q7SIG6, Q7YTB0, Q80Y84
Diamond homologs: A6NNX1, B9EKE5, M0RAU5, Q0IHI3, Q32PB2, Q3KNY5, Q7Z7H3, Q08CH6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
14 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 12 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2510 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:151710751:C:CA | donor_gain | 1.0000 |
| 1:151714497:G:GT | donor_gain | 1.0000 |
| 1:151714592:ACC:A | donor_gain | 1.0000 |
| 1:151714593:CCC:C | donor_gain | 1.0000 |
| 1:151715894:A:AC | donor_gain | 1.0000 |
| 1:151715895:C:CC | donor_gain | 1.0000 |
| 1:151721168:G:T | donor_gain | 1.0000 |
| 1:151721617:CAAG:C | donor_loss | 1.0000 |
| 1:151721619:AGG:A | donor_loss | 1.0000 |
| 1:151710457:C:T | acceptor_gain | 0.9900 |
| 1:151710747:ATCTC:A | donor_gain | 0.9900 |
| 1:151710799:T:A | donor_gain | 0.9900 |
| 1:151714525:GGGTG:G | donor_gain | 0.9900 |
| 1:151714526:GGTGG:G | donor_gain | 0.9900 |
| 1:151714587:GACTC:G | donor_loss | 0.9900 |
| 1:151714588:ACTC:A | donor_loss | 0.9900 |
| 1:151714589:CT:C | donor_loss | 0.9900 |
| 1:151714590:TCA:T | donor_loss | 0.9900 |
| 1:151714591:CACC:C | donor_loss | 0.9900 |
| 1:151714592:A:G | donor_loss | 0.9900 |
| 1:151714673:CATC:C | acceptor_gain | 0.9900 |
| 1:151714688:C:CT | acceptor_gain | 0.9900 |
| 1:151715874:AC:A | donor_gain | 0.9900 |
| 1:151715875:CC:C | donor_gain | 0.9900 |
| 1:151715899:T:TA | donor_gain | 0.9900 |
| 1:151716745:T:A | donor_gain | 0.9900 |
| 1:151721619:AGGTG:A | donor_gain | 0.9900 |
| 1:151722081:CCCA:C | acceptor_loss | 0.9900 |
| 1:151722083:CA:C | acceptor_loss | 0.9900 |
| 1:151722084:A:AG | acceptor_gain | 0.9900 |
AlphaMissense
604 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:151727616:C:A | A68D | 0.974 |
| 1:151727612:T:C | F67L | 0.971 |
| 1:151727614:T:A | F67L | 0.971 |
| 1:151727614:T:G | F67L | 0.971 |
| 1:151728771:T:C | F72L | 0.952 |
| 1:151728773:C:A | F72L | 0.952 |
| 1:151728773:C:G | F72L | 0.952 |
| 1:151722096:G:C | R32P | 0.949 |
| 1:151728772:T:C | F72S | 0.942 |
| 1:151722144:T:C | L48P | 0.936 |
| 1:151722117:T:C | L39P | 0.921 |
| 1:151722114:A:G | Y38C | 0.918 |
| 1:151722114:A:C | Y38S | 0.914 |
| 1:151727615:G:C | A68P | 0.914 |
| 1:151722106:C:A | N35K | 0.910 |
| 1:151722106:C:G | N35K | 0.910 |
| 1:151722156:T:C | F52S | 0.908 |
| 1:151728787:T:C | L77P | 0.906 |
| 1:151722109:A:C | E36D | 0.904 |
| 1:151722109:A:T | E36D | 0.904 |
| 1:151722108:A:T | E36V | 0.899 |
| 1:151722113:T:C | Y38H | 0.891 |
| 1:151722125:C:G | H42D | 0.884 |
| 1:151721620:G:C | K28N | 0.879 |
| 1:151721620:G:T | K28N | 0.879 |
| 1:151722155:T:C | F52L | 0.875 |
| 1:151722157:C:A | F52L | 0.875 |
| 1:151722157:C:G | F52L | 0.875 |
| 1:151722101:G:C | A34P | 0.874 |
| 1:151727595:C:A | P61Q | 0.872 |
dbSNP variants (sampled 300 via entrez): RS1000065736 (1:151725824 T>C), RS1000079312 (1:151716616 A>G), RS1000554424 (1:151716245 A>C), RS1000573281 (1:151720923 T>C), RS1000876036 (1:151724886 G>A), RS1000905845 (1:151724452 A>G), RS1001066102 (1:151714159 C>T), RS1001144648 (1:151727544 A>G), RS1001274120 (1:151717843 A>G,T), RS1001397320 (1:151710817 G>C), RS1001429815 (1:151710418 G>A), RS1001484236 (1:151718281 T>A), RS1001796153 (1:151724678 A>C), RS1001857224 (1:151712333 T>C), RS1002141620 (1:151728509 A>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008916_88 | Asthma | 1.000000e-25 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 6 |
| Aflatoxin B1 | decreases methylation, increases expression, increases methylation | 3 |
| Benzo(a)pyrene | affects methylation, increases methylation | 2 |
| propionaldehyde | increases expression | 1 |
| bisphenol A | decreases expression | 1 |
| dimethylselenide | decreases expression, increases expression, increases oxidation | 1 |
| butyraldehyde | increases expression | 1 |
| pentanal | increases expression | 1 |
| clothianidin | decreases expression | 1 |
| nutlin 3 | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Aldehydes | increases expression | 1 |
| Arsenic | increases methylation | 1 |
| Arsenicals | increases methylation | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Dactinomycin | affects cotreatment, increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Reactive Oxygen Species | increases expression, increases oxidation, decreases expression | 1 |
| Cadmium Chloride | increases abundance, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.